CompletedNot Applicable

Post-Marketing Surveillance of Lenvima in Korean Patients

South Korea132 participantsStarted 2016-11-10

Plain-language summary

The purpose of this post-marketing surveillance (PMS) is to observe the safety profile of Lenvima (lenvatinib) in normal clinical practice setting.

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Participants with approved indication for lenvatinib in Korea
✓. Participants who have written consent for use of personal and medical information for the study purpose

Number of Participants with Adverse Events, Serious Adverse Events, and Adverse Drug Reactions

Timeframe: Up to 1 year

NCT IDNCT02764554

SponsorEisai Korea Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2021-09-29